[Pharmacotherapeutic possibilities in obesity].
D001067:Appetite Depressants / Q000627:therapeutic use; D001645:Biguanides / Q000627:therapeutic use; D002351:Carrageenan / Q000627:therapeutic use; D006063:Chorionic Gonadotropin / Q000627:therapeutic use; D005277:Fenfluramine / Q000627:therapeutic use; D005947:Glucose / Q000627:therapeutic use; D013006:Growth Hormone / Q000627:therapeutic use; D006801:Humans; D008747:Methylcellulose / Q000627:therapeutic use; D009765:Obesity / Q000188:drug therapy*; D011374:Progesterone / Q000627:therapeutic use*; D013963:Thyroid Hormones / Q000627:therapeutic use
D001067:Appetite Depressants; D001645:Biguanides; D006063:Chorionic Gonadotropin; D013963:Thyroid Hormones; D005277:Fenfluramine; D011374:Progesterone; D002351:Carrageenan; D013006:Growth Hormone; D008747:Methylcellulose; D005947:Glucose
Pharmakotherapeutische Möglichkeiten bei der Adipositas